BRAIDWELL LP
13F filer · CIK 1920938 · Stamford, CT
Summary
BRAIDWELL LP reported $2.70B across 86 positions in its 13F for 2026 Q2, filed Aug 14, 2026. The largest holdings are CAI (5.4%), HNGE (4.1%), GKOS (3.1%). Versus 2026 Q1, leaving options aside, it opened 24 new positions, added to 21, trimmed 36 and sold out of 26.
Reported value$2.70B
Positions86
Report period2026 Q2
FiledAug 14, 2026
New positions24
Added21
Trimmed36
Sold out26
Top 25 holdings
By reported value, options listed separately · change vs 2026 Q1
Weight 5.4%Value $147.12MPrice $31.55Shares 8.26M +3.08%Since Jun 30 +77.05%
Weight 4.1%Value $110.40MPrice $92.45Shares 1.33M -8.59%Since Jun 30 +11.39%
Weight 3.1%Value $82.73MPrice $158.56Shares 592K -22.47%Since Jun 30 +13.45%
Weight 3.0%Value $81.14MPrice $39.79Shares 2.00M -14.94%Since Jun 30 -2.07%
Weight 2.9%Value $78.08MPrice $85.79Shares 879K -5.72%Since Jun 30 -3.37%
Weight 2.9%Value $77.82MPrice $112.60Shares 654K +7.22%Since Jun 30 -5.34%
Weight 2.7%Value $71.76MPrice $19.29Shares 4.92M -12.45%Since Jun 30 +32.21%
Weight 2.6%Value $69.63MPrice $89.92Shares 1.79M -1.72%Since Jun 30 +130.80%
Weight 2.5%Value $68.29MPrice $36.72Shares 1.13M -15.47%Since Jun 30 -39.17%
ALPHATEC HLDGS INCNo ticker matchAdd
Weight 2.4%Value $66.18MPrincipal $69.12M +12.17%
Weight 2.2%Value $59.33MPrice $11.71Shares 2.45M -23.55%Since Jun 30 -51.61%
Weight 2.1%Value $57.96MPrice $87.83Shares 595K -33.89%Since Jun 30 -9.90%
Weight 2.1%Value $56.66MPrice $140.44Shares 336K -48.45%Since Jun 30 -16.67%
Weight 2.1%Value $56.50MPrice $10.37Shares 6.53M +200.61%Since Jun 30 +19.88%
Weight 2.0%Value $55.40MPrice $14.91Shares 3.28M -8.60%Since Jun 30 -11.62%
Weight 2.0%Value $54.31MPrice $7.63Shares 8.70M -15.01%Since Jun 30 +22.28%
Weight 1.8%Value $47.94MPrice $337.08Shares 129K -29.30%Since Jun 30 -9.31%
Weight 1.7%Value $45.48MPrice $389.63Shares 115KSince Jun 30 -1.91%
Weight 1.7%Value $44.82MPrice $678.60Shares 89K -3.79%Since Jun 30 +35.35%
Weight 1.6%Value $43.36MPrice $112.00Shares 378K +12.03%Since Jun 30 -2.33%
Weight 1.6%Value $42.32MPrice $98.56Shares 381K +22.70%Since Jun 30 -11.23%
Weight 1.6%Value $42.15MPrice $20.75Shares 1.62M +81.08%Since Jun 30 -20.22%
Weight 1.5%Value $41.65MPrice $20.22Shares 1.65M -33.38%Since Jun 30 -20.08%
Weight 1.5%Value $41.62MPrice $55.69Shares 597K -41.30%Since Jun 30 -20.15%
Weight 1.5%Value $40.50MPrice $82.73Shares 610K +85.10%Since Jun 30 +24.56%
| Stock | Weight | Value | Since Jun 30 | Shares change | Action |
|---|---|---|---|---|---|
| 5.4% | $147.12M | +77.05% | +3.08% | Add | |
| 4.1% | $110.40M | +11.39% | -8.59% | Trim | |
| 3.1% | $82.73M | +13.45% | -22.47% | Trim | |
| 3.0% | $81.14M | -2.07% | -14.94% | Trim | |
| 2.9% | $78.08M | -3.37% | -5.72% | Trim | |
| 2.9% | $77.82M | -5.34% | +7.22% | Add | |
| 2.7% | $71.76M | +32.21% | -12.45% | Trim | |
| 2.6% | $69.63M | +130.80% | -1.72% | Trim | |
| 2.5% | $68.29M | -39.17% | -15.47% | Trim | |
| ALPHATEC HLDGS INCNo ticker match | 2.4% | $66.18M | — | +12.17% | Add |
| 2.2% | $59.33M | -51.61% | -23.55% | Trim | |
| 2.1% | $57.96M | -9.90% | -33.89% | Trim | |
| 2.1% | $56.66M | -16.67% | -48.45% | Trim | |
| 2.1% | $56.50M | +19.88% | +200.61% | Add | |
| 2.0% | $55.40M | -11.62% | -8.60% | Trim | |
| 2.0% | $54.31M | +22.28% | -15.01% | Trim | |
| 1.8% | $47.94M | -9.31% | -29.30% | Trim | |
| 1.7% | $45.48M | -1.91% | — | New | |
| 1.7% | $44.82M | +35.35% | -3.79% | Trim | |
| 1.6% | $43.36M | -2.33% | +12.03% | Add | |
| 1.6% | $42.32M | -11.23% | +22.70% | Add | |
| 1.6% | $42.15M | -20.22% | +81.08% | Add | |
| 1.5% | $41.65M | -20.08% | -33.38% | Trim | |
| 1.5% | $41.62M | -20.15% | -41.30% | Trim | |
| 1.5% | $40.50M | +24.56% | +85.10% | Add |
Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).
Largest buys in 2026 Q2
Largest sells in 2026 Q2
NEOGENOMICS INCNo ticker match≈ $75.37MTrim
Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.